NasdaqGM:ATAIPharmaceuticals
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift
If you are wondering whether AtaiBeckley is still reasonably priced after its recent run, this article will help you size up what you are paying for each dollar of potential future value.
The stock recently closed at US$3.64, with returns of 149.3% over the last year and 91.6% over three years, alongside a 2.9% decline over the past week and a 10.3% decline over the last month, so recent trading has been choppy even as longer term returns remain strong.
Recent news has focused on AtaiBeckley...